People recovering from COVID-19 would likely experience persistent injuries and inflammation at the center months after the initial infection, even if they have not been hospitalized, a small new test suggests.
The study, published on Monday, July 27 in the journal JAMA Cardiology, analyzed a hundred adults over forty-five to 53 in Germany who had recently completed COVID-19. About one-third of participants had to be hospitalized, while the other two-thirds were able to do so at home. In MRIs taken more than two months after diagnosis, about three-quarters of these patients showed symptoms of heart abnormalities, adding central muscle inflammation or myocarditis. Many patients also had detectable degrees of a protein in their blood called troponin, possibly implying central damage, such as injuries after a central attack. (Troponin is a protein found in the central cells that is released into the blood when the central muscle is damaged, according to the University medical center of Rochester).
However, what these findings mean precisely for the long-term patient conditioning center is unclear, the authors said. Cardiac abnormalities observed during the test sometimes occur with other respiratory diseases such as influenza and may be transient; In fact, mild cases of central inflammation may show no symptoms and improve on their own, according to the National Heart, Lung and Blood Institute.
But given the frequency of central defects in this group, the effects “require urgent confirmation” in a larger population, the authors concluded.
The findings are potentially worrisome because inflammation and damage in the center can lead to a failure at the center, a life-threatening disease that occurs when the central muscle pumps enough blood to meet the body’s overall demands.
Researchers and patients exceeded the prevalence of these heart abnormalities and the fact that they were still pronounced weeks after patients recovered, the lead author of the study, Dr Valentina Puntmann, of Frankfurt University Hospital told UPI.
“Although we still have no direct evidence of the consequences [in the long term], such as the progression of the Array center failure … it is quite imaginable that in a few years this burden will be enormous,” Puntmann said.
Related: The mystery between coronavirus and heart.
“The 10 amazing facts about your heart
—28 devastating infectious diseases
-20 of the worst epidemics and pandemics in history
Although first identified primarily as a lung infection, COVID-19 has now been linked to injuries to several other organs of the body, adding the brain and heart. But many of these headaches have been observed in patients in poor health enough to be hospitalized.
Of the hundred patients in the new study, 67 were not hospitalized and most of these Americans evolved mild to moderate symptoms. Some patients had underlying situations such as high blood pressure, diabetes or asthma, but Maximum did not have them. Patients were followed by an MRI approximately two to 3 months after their initial diagnosis. Currently, about one-third of patients reported persistent symptoms of COVID-19, such as shortness of breath and general exhaustion. Some patients had heart palpitations and chest pain after diagnosis, but none had any idea they had a problem at the COVID-19-related center, STAT reported.
Researchers compared scans of recovered COVID-19 patients with those of ages and physical situations that were not yet inflamed with COVID-19.
Overall, 78% of patients with recovered COVID-19 showed symptoms of some type of heart abnormality. The maximum non-unusual central challenge was inflammation of the central muscle, or myocarditis, in 60% of patients. Some patients have also shown symptoms of inflammation of the pericardium, the tissue surrounding the center. Myocarditis occurs infrequently with influenza, adenoviruses and other respiratory viruses, much less common, for example, in less than 10% of influenza cases, according to a 2012 study in the journal Influenza Research and Treatment.
The presence of heart abnormalities not similar to the severity of COVID-19 disease of the participants examined or its underlying condition.
“Our effects demonstrate that participants with a relative rarity of pre-existing cardiovascular [conditions] and with a home recovery had a common inflammatory cardiac commitment” after COVID-19, the authors said.
Another study, also published Monday in JAMA Cardiology, analyzed the post-mortem effects of 39 other older people who died of COVID-19 and discovered evidence of SARS-CoV-2, the culprit coVID-19 virus, in the central tissue of 61% of patients.
In an editorial that accompanies these studies, Dr. Clyde Yancy, cardiologist at Northwestern’s Feinberg School of Medicine, and Dr. Gregg Fonarow, a cardiologist at UCLA’s Geffen School of Medicine, said that together, these two studies raise considerations about COVID-19 pandemics. can lead to a central fault buildup.
“We are susceptible to a new and very apparent fear that cardiomyopathy [central muscle disease] and COVID-19-related failure of the center may potentially evolve as the herbal history of this infection becomes clear,” the editorial said.
Publishers added that they needed to “generate more anxiety,” but called for rigorous studies to verify or refute the new findings.
Originally on Live Science.
Stay up-to-date on the coronavirus outbreak by registering today in our newsletter.
Thank you for signing up for Live Science. You will soon receive a verification email.
There’s a problem. Refresh the page and re-consult.
Live Science is from Future US Inc., a foreign media organization and a leading virtual publisher. Visit our corporate website.